药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Alizapride
Dantron
The risk or severity of adverse effects can be increased when Dantron is combined with Magnesium carbonate.
Alizapride
Erdafitinib
The risk or severity of adverse effects can be increased when Magnesium carbonate is combined with Erdafitinib.
Alizapride
Dexmethylphenidate
Magnesium carbonate can cause a decrease in the absorption of Dexmethylphenidate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
TMC-310911
Magnesium carbonate can cause a decrease in the absorption of TMC-310911 resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Asunaprevir
Magnesium carbonate can cause a decrease in the absorption of Asunaprevir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Isavuconazole
Magnesium carbonate can cause a decrease in the absorption of Isavuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Bifonazole
Magnesium carbonate can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Albaconazole
Magnesium carbonate can cause a decrease in the absorption of Albaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Ravuconazole
Magnesium carbonate can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Abafungin
Magnesium carbonate can cause a decrease in the absorption of Abafungin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alizapride
Gantacurium
The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Gantacurium.
Alizapride
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione.
Alizapride
Barbital
The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Barbital.
Alizapride
Homatropine
The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Homatropine.
Alizapride
Sulfate ion
The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Magnesium carbonate.
Alizapride
Sodium cation
The therapeutic efficacy of Sodium cation can be decreased when used in combination with Magnesium carbonate.
Alizapride
Sodium phosphate, dibasic, unspecified form
The therapeutic efficacy of Sodium phosphate, dibasic, unspecified form can be decreased when used in combination with Magnesium carbonate.
Alizapride
Sodium phosphate, monobasic, unspecified form
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Magnesium carbonate.
Alizapride
Sodium phosphate, dibasic
The therapeutic efficacy of Sodium phosphate, dibasic can be decreased when used in combination with Magnesium carbonate.
Alizapride
Sodium ascorbate
The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Magnesium carbonate.